Submitter:

Name:Owen Ambur

Email:Owen.Ambur@verizon.net

Organization:

Name:Institute for Systems Biology

Acronym:ISB

Description:
The Institute for Systems Biology is a premier, nonprofit research organization based in Seattle, Washington.

Stakeholder(s):

• Leroy Hood: It was founded in 2000 by Leroy Hood, a world-renowned systems biologist; Alan Aderem, a leading immunologist; and Ruedi Aebersold, a cutting-edge protein chemist. ABOUT DR. LEE HOOD Dr. Hood is a pioneer in the systems approach to biology and medicine. His research has focused on the study of molecular immunology, biotechnology and genomics. Dr. Hood's professional career began at Caltech, where he and his colleagues developed the DNA gene sequencer and synthesizer and the protein synthesizer and sequencer--four instruments that paved the way for the successful mapping of the human genome. A pillar in the biotechnology field, Dr. Hood has played a role in founding more than fourteen biotechnology companies, including Amgen, Applied Biosystems, Darwin, The Accelerator and Integrated Diagnostics. He is a member of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. Of the 6,000+ scientists world-wide who belong to one or more of these academies, Dr. Hood is one of only fifteen people accepted to all three. He is also a member of the American Philosophical Society and a Fellow of the American Academy of Arts and Sciences. His work has been widely published, and he has coauthored numerous textbooks in biochemistry, immunology, molecular biology and genetics, as well as a popular book on the human genome project, The Code of Codes. He is the recipient of numerous awards, including the Lasker Award for Studies of Immune Diversity, the Kyoto Prize in advanced technology, the Heinz Award for pioneering work in Systems Biology, and the coveted NAE 2011 Fritz J. and Delores H. Russ Prize for automating DNA sequencing that revolutionized biomedicine and forensic science. In addition to having received 17 honorary degrees from prestigious universities in the US and abroad, Dr. Hood has published more than 700 peer reviewed articles and currently holds 36 patents. He received the 2011 National Medal of Science, which was awarded to him during a White House ceremony in February 2013.


• Ruedi Aebersold: Co-founder


• Nitin Baliga, PhD: Senior Vice President and Director


• Nathan Price, PhD: Associate Director


• James R. Ladd: Senior Vice President for Finance and Operations


• Sissy Walsh Bouchard, EdD: Vice President for Development


• Rob Lipshutz: Senior Vice President for Strategic Partnerships & Chief Business Officer


• ISB Board of Directors


• Louis G. Lange, MD, PhD: Chairman of the Board - Senior Advisor, Gilead


• Mark Ashida: CEO, Symform


• Bill Bowes: Co-Founder, U.S. Venture Partners


• Thomas J. Cable: Board Member, Omeros Corporation


• Stephen M. Graham: Managing Partner, Seattle Office, Fenwick & West LLP


• Leroy Hood, MD, PhD: President, Institute for Systems Biology


• Douglas Howe: President, Touchstone Corporation


• Daniel T. Ling: Retired, Microsoft Research, Corporate Vice President


• Craig Mundie: Senior Advisor to the CEO, Microsoft


• Robert T. Nelsen: Co-founder and Managing Director, ARCH Venture Partners


• Roger Perlmutter, MD, PhD
: Executive Vice President and President, Merck Research Laboratories


• J. Leighton Read, MD: General Partner, Alloy Ventures


• David A. Sabey: President, Sabey Corporation & Sabey Construction


• Drew Senyei, MD: Managing Director, Enterprise Partners Venture Capita


• ISB Directors Emeriti


• Steve Clifford


• Fred Frank


• Chuck Hirsch


• Garry Menzel, PhD


• George Rathmann, PhD


• Hank Riggs


• H. Jon Runstad


• ISB Faculty


• John Aitchison: John Aitchison Group -- Complex molecular machines, cell biology, influenza


• Nitin Baliga: Nitin Baliga Group -- Systems biology of organism-environment interactions


• Aimée Dudley: Aimée Dudley Group -- Genetics, gene regulatory networks, technology development


• Lee Hood: Lee Hood Group -- Adaptive immunity, genomics, and biotechnology


• Sui Huang: Sui Huang Group -- Molecular and cell biology, cancer biology, gene regulatory networks and theory of complex systems


• Robert Moritz: Robert Moritz Group -- Proteomics, protein chemistry, technology development


• Adrian Ozinsky: Adrian Ozinsky Group -- Immunology, cell biology and biotechnology


• Nathan Price: Nathan Price Group -- Computational biology, biochemical reaction networks, genome-scale models, translational bioinformatics


• Jeff Ranish: Jeff Ranish Group -- Proteomics, macromolecular complexes and transcriptional regulation


• Ilya Shmulevich: Ilya Shmulevich Group -- Computational biology, signal and image processing


• Kai Wang: Principal Scientist


• ISB Senior Research Scientists & Engineers


• Gareth Cromie: Genome Assembly QTL Mapping


• Kerry Deutsch


• Eric Deutsch: Database design Proteomics


• Richard Gelinas: Stem Cell Biology Cell and Molecular Biology


• Gustavo Glusman: Computational Genomics and Transcriptomics


• Nat Goodman: Computational biology Software/database development


• Andrew Keller: Computational Biology Proteomics


• Chris Lausted: Instrumentation and Microarray technology


• Inyoul Lee: Genomics, Prion disease biology


• William Longabaugh: Software engineering, computer graphics, software applications development


• Monica Orellana: Oceanography Phytoplankton physiological ecology


• Christopher Plaisier: Human Genetics, Gene Expression, Computational Biology, Bioinformatics, Statistics


• Shizhen Qin: Genomics, Proteomics


• David Reiss: Computational Biology


• Jared Roach: Computational Biology Genetics Genomics Immunology


• Hector Rovira: Enterprise and Web Software Development


• Lee Rowen: Genomics


• Arian Smit: Genomics Computational Biology


• Jennifer Smith: Genomics Cell Biology


• Sergey Stolyar


• Vesteinn Thorsson: Computational Biology


• Qiang Tian: Cancer and Stem Cell Biology, Translational Systems Medicine


• Kathie Walters: Virology, genomics, host-pathogen interactions


• Julian Watts: Cell Biology and Proteomics


• Wei Yan: Proteomics, Biochemistry


• ISB Affiliate Faculty


• Alan Aderem: Seattle BioMed, HIV/AIDS, Immunology, Systems Biology


• Ruedi Aebersold: Institute of Molecular Systems Biology, Proteomics, Protein Chemistry


• Rudi Balling: Luxembourg Centre for Systems Biomedicine, Systems Biology


• Richard Bonneau: New York University's Center for Comparative Functional Genomics, Computational Biology and Structural Biology


• Jung-Hsien Chiang: National Cheng Kung University Department of Computer Science and Information Engineering, Bioinformatics, Text Mining, Pattern Clustering, and Modeling of Systems Biology Problems


• Nick Flann: Utah State University Department of Computer Science, Modeling Multiscale Systems


• Timothy Galitski: EMD Millipore, Microbiology, Genetics of Systems Biology


• Carl Hansen: University of British Columbia Department of Physics and Astronomy, Physics


• Stu Kauffman: University of Vermont, Tampere University of Technology and Santa Fe Institute, Developmental Biology, Combinatorial Chemistry, Molecular Evolution


• Gilbert Omenn: University of Michigan, Clinical Informatics, Databases and Computing, Medical and Translational Research, Proteomics, and Systemic Modeling and Systems Biology


• Peter Small: Bill & Melinda Gates Foundation, Infectious diseases, comparative genomics, bacterial population genetics


• Ger van den Engh: BD BioSciences, Biophysics, Advanced Cytometry, Use of flow cytometry in environmental microbiology


• Olli Yli-Harja: Tampere University of Technology Department of Signal Processing, Computational Systems Biology


• ISB Scientific Advisory Board


• Eric H. Davidson, Ph.D.: California Institute of Technology


• Trey Ideker, Ph.D.: University of California, San Diego


• C. Ronald Kahn, M.D., D.Sc.: Harvard Medical School


• Ed Lazowksa, Ph.D.: University of Washington


• Bernhard Ø. Palsson, Ph.D.: University of California, San Diego


• Stephen Quake, Ph.D.: Stanford University


• Ellen Rothenberg, Ph.D.: California Institute of Technology


• Gregory Stephanopoulos, Ph.D.: Massachusetts Institute of Technology


• Irving L. Weissman, M.D.: Stanford University Medical Center


• Biologists: ISB was established as an untraditional institution, where scientific collaboration could take place across disciplines, where biologists and technologists could commingle, and where the future of research and medicine could take foot.


• Technologists


• Geneticists


• Computer Scientists


• Chemists


• Engineers


• Mathematicians


• Immunologists


• ISB Staff: Since 2000, ISB has grown to more than 230 staffers, which includes 10 faculty members and laboratory groups.